Repligen (NASDAQ:RGEN) Releases Earnings Results, Beats Expectations By $0.05 EPS

Repligen (NASDAQ:RGEN – Get Rating) posted its quarterly earnings results on Tuesday. The biotechnology company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.05, Briefing.com reports. The firm had revenue of $182.70 million for the quarter, compared to analyst estimates of $181.43 million. Repligen had a return on […]

Related Keywords

United States ,America ,Craig Hallum ,Repligen Corp ,Norges Bank ,Invesco Ltd ,Eagle Asset Management Inc ,Deutsche Bank Aktiengesellschaft ,Keycorp ,Get Rating ,Bank Aktiengesellschaft ,Street Corp ,Asset Management ,Asia Pacific Region ,Repligen Daily ,Repligen ,Nasdaq Rgen ,Rgen ,Medical ,75991610 ,Earnings ,